Exchange: STO Sector: Healthcare Industry: Medical Devices
-0.93% SEK2.13
America/New_York / 31 des 1970 @ 19:00
RATING 2022-08-29 |
---|
B+ |
Buy |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Buy | |
Return On Equity: | Neutral | |
Return On Asset: | Neutral | |
DE: | Neutral | |
P/E: | Strong Sell | |
Price To Book: | Strong Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
4/20 | 1/21 | 2/21 | 3/21 | 4/21 | 1/22 | |
Revenue | n/a | n/a | n/a | n/a | ||
Gr.Profit | n/a | n/a | ||||
Ebit | n/a | n/a | ||||
Asset | n/a | |||||
Debt | n/a | n/a | n/a | n/a | n/a | n/a |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -5.17 | sector: PE 19.76 |
PE RATIO: COMPANY / INDUSTRY |
---|
-0.10x |
Company: PE -5.17 | industry: PE 54.10 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
SEK 0 - 0 ( +/- 0.00%) |
ATR Model: 14 days |
GPX Medical AB operates as a medical technology company. It offers neonatal intensive care with NEOLA, a medical device that offer continuous lung monitoring and real-time alerts of life-threatening complications using technology that measures lung volume changes and oxygen gas concentration. NEOLA provide intensive care and healthier lives for preterm born infants. The company was founded in 2016 and headquartered in Lund, Sweden.